Good morning and welcome to PDS Biotech's 4th quarter in full year 2024 earnings conference call. Thank you, operator. Good morning, everyone, and welcome to PDS Biotech's 2024 results and clinical ...
In October 2024, updated results from the IMMUNOCERV Phase 2 clinical trial in locally advanced cervical cancer patients treated with Versamune ® HPV and chemoradiotherapy were presented at the 66 th ...
Hours after Jay Bhattacharya was confirmed as NIH director, the agency directed staff to identify contracts related to ...
The Christian Post on MSN15h
Senate confirms Trump's pick, Dr. Jay Bhattacharya, to lead NIHThe United States Senate has confirmed an outspoken critic of COVID-19 lockdowns as the new director of the National ...
Jay Bhattacharya, a Stanford University health economist who gained notoriety for his criticism of the NIH’s handling of the COVID-19 pandemic, secured the confirmation with a 53-to-47 party-line vote ...
India Today on MSN22h
Jay Bhattacharya becomes NIH chief: 5 bold claims he made in Senate hearingJau Bhattacharya, who is an Indian-origin professor at Stanford School of Medicine, is confirmed as the Director of NIH.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback